Delivery Order SPE2DE24DA017-SPE2D625F6586

Award Date 10/17/24
Potential Completion Date 10/22/24
Potential Value $2.5K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the Arthrex ACP Double Syringe System, awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The fixed-price delivery order, valued at $1,650.00, has an ultimate completion date of November 8, 2024. Arthrex, a for-profit Subchapter S Corporation, has a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, valued at $471,048,172.66...
This federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, was issued by the Defense Logistics Agency's Medical Supply Chain. The $2,311.02 fixed-price delivery order is for the ARTHREX ACP DOUBLE SYRINGE SYSTEM, a specialized medical device. Arthrex holds a larger $471,048,172.66 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency that allows VA medical centers to acquire the company's innovative orthopedic...
The U.S. government agency, the Defense Logistics Agency's Medical Supply Chain, awarded a Fixed Price with Economic Price Adjustment delivery order contract to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract, valued at $2,475.00, is for the provision of the ARTHREX ACP DOUBLE SYRINGE SYSTEM, a specialized medical device. This award is not a set-aside contract. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, is for the provision of the ARTHREX ACP DOUBLE SYRINGE SYSTEM. The $1,650 fixed-price with economic price adjustment contract is a delivery order awarded by the Defense Logistics Agency's Medical Supply Chain and has a completion date of June 18, 2025. The contract is not set aside for a specific business type. Arthrex holds a significant single-award Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the delivery of an Arthrex ACP Double Syringe System, a specialized medical device used in orthopedic procedures. The contract has a fixed price with economic price adjustment, a ceiling value of $3,300.00, and runs through November 15, 2024. This order is part of a larger Indefinite Delivery...
This federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, was issued by the Defense Logistics Agency's Medical Supply Chain. The $1,926.00 fixed-price delivery order is for an ACP KIT SERIES I, with a period of performance through November 13, 2024. The contract is not designated as a set-aside. Arthrex holds a significant $471,048,172.66 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, which allows VA medical...
This federal contract award, valued at $2,475.00, was issued by the Medical Supply Chain of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the provision of Arthrex's ACP Double Syringe System, a specialized medical device used in orthopedic procedures. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type and has an ultimate completion date of October 21,...
This federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, is for the delivery of the ARTHREX ACP DOUBLE SYRINGE SYSTEM. The $2,475.00 fixed-price with economic price adjustment contract was awarded on June 25, 2025, with a completion date of June 30, 2025. The contract is funded by the Defense Logistics Agency's Medical Supply Chain and is not set aside for any specific business type. Arthrex holds a significant single-award Indefinite...
The federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, is for the delivery of the ARTHREX ACP DOUBLE SYRINGE SYSTEM. The $5,775.00 fixed-price with economic price adjustment contract was awarded by the Medical Supply Chain of the Defense Logistics Agency, a defense agency. The contract has an ultimate completion date of October 22, 2024 and does not have a set-aside designation, indicating Arthrex's strong competitive position....
This federal contract award is for the delivery of the Arthrex ACP Double Syringe System, a specialized medical device, to the Defense Logistics Agency's Medical Supply Chain. The $4,950.00 fixed-price delivery order was awarded to Arthrex Inc., a for-profit Subchapter S Corporation and global leader in minimally invasive orthopedic products and procedures. The contract has an ultimate completion date of November 27, 2024. Arthrex holds a larger Indefinite Delivery Contract (IDC) with the...
  • SPE2DE24DA017
    Indefinite Delivery Contract
  • SPE2DE24DA017-SPE2D625F6586
    Delivery Order

This federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products, was issued by the Defense Logistics Agency's Medical Supply Chain. The $2,475.00 fixed-price delivery order is for the Arthrex ACP Double Syringe System, a specialized medical device. Arthrex has a significant Indefinite Delivery Contract (IDC) worth $471,048,172.66 with the Defense Logistics Agency, which allows VA medical centers to acquire Arthrex's innovative orthopedic technologies through task orders. This contract, which runs from June 2024 to September 2029, provides a wide range of Arthrex products, including surgical implants, arthroscopic instruments, and joint replacement technologies, to support the diverse medical needs of veterans and military personnel. The contract award is not designated as a set-aside.

Generated 1/16/25, 9:29 AM